View all IQVIA events
-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Research & Development
-
Real World Evidence
-
Commercialization
-
Safety & Regulatory Compliance
-
Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
- Information Partner Services
- Financial Institutions
- Global Health
- Government
- Patient Associations
- Payers
- Providers
THERAPEUTIC AREAS
- Cardiovascular
- Cell and Gene Therapy
- Central Nervous System
- GI & Hepatology
- Infectious Diseases and Vaccines
- Oncology
- Pediatrics
- Rare Diseases
- View All
Impacting People's Lives
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewResearch & Development Quick Links
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWReal World Evidence Quick Links
See markets more clearly. Opportunities more often.
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWCommercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWSafety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWTechnology Quick Links
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
BLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSTHE IQVIA INSTITUTE
An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSFEATURED INNOVATIONS
-
IQVIA Connected Intelligence™
-
IQVIA Healthcare-grade AI™
-
IQVIA AI Assistant
-
Human Data Science Cloud
-
IQVIA Innovation Hub
-
Decentralized Trials
-
Patient Experience Solutions with Apple devices
WHO WE ARE
- Our Story
- Our Impact
- Commitment to Global Health
- Code of Conduct
- Sustainability
- Privacy
- Executive Team
NEWS & RESOURCES
Unlock your potential to drive healthcare forward
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
IQVIA AI is Healthcare-grade AI
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
Meet the IQVIA AI Assistant
Your new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MORE
Your healthcare data deserves more than just a cloud.
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
Proven, faster DCT solutions
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
IQVIA Patient Experience Solutions with Apple devices
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREIQVIA Careers
Featured Careers
Stay Connected
WE'RE HIRING
"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLES
Join us at the world's premier oncology event.
ASCO's robust scientific and education programs will be held online again this year. We look forward to connecting with customers and colleagues virtually in June.
Imagine a world in which you move oncology innovation forward by bringing treatments to patients faster and more precisely than ever before. By making intelligent connections, IQVIA brings together R&D, real world and commercial solutions that help you connect the dots, capture best practice, and be at the forefront of today's oncology development.
Visit our online exhibit at ASCO to learn how our specialized oncology teams with IQVIA, IQVIA Biotech and Q2 Solutions can support your study from clinical to commercial.
We hope to connect with you at the 2021 ASCO Annual Meeting!
Click here for more information.
ASCO's robust scientific and education programs will be held online again this year. We look forward to connecting with customers and colleagues virtually in June.
Imagine a world in which you move oncology innovation forward by bringing treatments to patients faster and more precisely than ever before. By making intelligent connections, IQVIA brings together R&D, real world and commercial solutions that help you connect the dots, capture best practice, and be at the forefront of today's oncology development.
Visit our online exhibit at ASCO to learn how our specialized oncology teams with IQVIA, IQVIA Biotech and Q2 Solutions can support your study from clinical to commercial.
We hope to connect with you at the 2021 ASCO Annual Meeting!
Click here for more information.
IQVIA publications in ASCO21 virtual scientific program
The American Society of Clinical Oncology 2021 Annual Meeting features 21 abstracts from IQVIA demonstrating Connected Intelligence solutions spanning precision medicine, immuno-oncology trials, and real world insights during a global pandemic.
Featured Abstracts
Abstract
Evaluating real-world overall survival (rwOS) across oncology data sources: Friends of Cancer Research non-small cell lung cancer pilot study.
Publication-Only Abstracts: Health Services Research and Quality Improvement
Abstract
Advanced tumor progression detection by leveraging EHR based convolutional neural network boosting approaches.
Publication-Only Abstracts: Care Delivery and Regulatory Policy
Abstract
Why are oncologists not testing all NSCLC patients for biomarkers in the U.S. market?
Publication-Only Abstracts: Lung Cancer—Non-Small Cell Metastatic
See below for more ASCO21 abstracts from IQVIA authors.
Breast cancer survivorship and level of institutional involvement utilizing integrative oncology.
Publication-Only Abstracts: Health Services Research and Quality Improvement
View Abstract
Awareness, perceptions, and usage of whole person integrative oncology practices: Similarities and differences between breast cancer patients and oncologists.
Publication-Only Abstracts: Symptoms and Survivorship
View Abstract
Results from VERONICA: A randomized, phase II study of second-/third-line venetoclax (VEN) + fulvestrant (F) versus F alone in estrogen receptor (ER)-positive, HER2-negative, locally advanced, or metastatic breast cancer (LA/MBC).
Oral Abstract Session: Breast Cancer—Metastatic
View Abstract
A phase 1 study of an off-the shelf, multi-neoantigen vector (ADXS-503) in subjects with metastatic non-small cell lung cancer (NSCLC) progressing on pembrolizumab as last therapy.
Poster Session: Developmental Therapeutics—Immunotherapy
View Abstract
An international, multicenter, real-world analysis of epithelial ovarian cancer treatment and outcomes.
Poster Session: Gynecologic Cancer
View Abstract
Obinutuzumab short-duration infusion (SDI) in previously untreated advanced follicular lymphoma: Results from the end of induction analysis of the phase IV GAZELLE study.
Poster Session: Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
View Abstract
Patient-reported symptoms, functioning, and quality of life (QoL) in patients treated with cemiplimab monotherapy for first-line treatment of advanced NSCLC with PD-L1 ≥50%: Results from EMPOWER-Lung 1 study.
Poster Session: Lung Cancer—Non-Small Cell Metastatic
View Abstract
Health-related quality of life (HRQoL) in patients (pts) with locally advanced basal cell carcinoma (laBCC) treated with cemiplimab: Analysis of a phase II, open-label clinical trial.
Poster Session: Melanoma/Skin Cancers
View Abstract
The impact of cancer-related diarrhea on changes in cancer therapy patterns.
Poster Session: Symptoms and Survivorship
View Abstract
Oncology clinical research landscape in Middle East and North Africa (MENA) region: Challenges and proposed solutions.
Publication-Only Abstracts: Care Delivery and Regulatory Policy
View Abstract
OEN: Multi-center, international, real-world evidence studies performed using health records without data pooling—The use of a common data model and shared analytical methods.
Publication-Only Abstracts: Care Delivery and Regulatory Policy
View Abstract
Phase I study of BJ-001, a tumor-targeting interleukin-15 fusion protein, in patients with solid tumor.
Publication-Only Abstracts: Developmental Therapeutics—Immunotherapy
View Abstract
Cost-effectiveness of atezolizumab monotherapy versus pembrolizumab monotherapy for first-line (1L) treatment of metastatic non-small cell lung cancer (mNSCLC).
Publication-Only Abstracts: Health Services Research and Quality Improvement
View Abstract
Characterizing unplanned resource utilization associated with cancer-related diarrhea.
Publication-Only Abstracts: Health Services Research and Quality Improvement
View Abstract
Healthcare utilization and costs associated with cancer-related diarrhea.
Publication-Only Abstracts: Health Services Research and Quality Improvement
View Abstract
Incidence of pneumonitis among limited-stage small cell lung cancer patients exposed to concurrent chemoradiation: A systematic literature review and meta-analysis.
Publication-Only Abstracts: Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
View Abstract
Chemoradiation-induced pneumonitis in patients with unresectable stage III non-small cell lung cancer: A meta-analysis.
Publication-Only Abstracts: Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
View Abstract
Psychometric properties of patient reported outcome (PRO) instruments in patients with small cell lung cancer (SCLC) in RESILIENT part 1.
Publication-Only Abstracts: Symptoms and Survivorship